Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study (Q40138681)

From Wikidata
Jump to navigation Jump to search
scientific article published on 15 September 2015
edit
Language Label Description Also known as
English
Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
scientific article published on 15 September 2015

    Statements

    Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study (English)
    Richard Rupp
    Gary Joseph Luckasen
    Judith Lee Kirstein
    Joseph D Santangelo
    Marsha Raanan
    Mary Kathryn Smith
    Derek Wallace
    Gilad S Gordon
    Dan T Stinchcomb
    15 September 2015
    6351-6359

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit